Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterization of the Retinal Phenotype Using Multimodal Imaging in Novel Compound Heterozygote Variants of CYP2U1.

Ophthalmology science·2024

Same author

Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration.

Lancet (London, England)·2024

Same author

QTL mapping of human retina DNA methylation identifies 87 gene-epigenome interactions in age-related macular degeneration.

Nature communications·2024

Same author

Adverse COVID-19 outcomes in American Veterans with age-related macular degeneration: a case-control study.

BMJ open·2023

Same author

A deep network DeepOpacityNet for detection of cataracts from color fundus photographs.

Communications medicine·2023

Same author

Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.

Ophthalmology·2023

Search research articles

Related Experiment Video

Updated: May 16, 2026

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Macular telangiectasia type 2.

Peter Charbel Issa¹, Mark C Gillies, Emily Y Chew

¹Department of Ophthalmology, University of Bonn, Ernst-Abbe-Str. 2, 53127 Bonn, Germany. peter.issa@ukb.uni-bonn.de

Progress in Retinal and Eye Research

|December 11, 2012

Summary

This summary is machine-generated.

Macular telangiectasia type 2 is a rare eye condition affecting vision. Current treatments show limited efficacy, highlighting the need for new therapeutic strategies.

More Related Videos

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Experiment Videos

Last Updated: May 16, 2026

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Area of Science:

Ophthalmology
Retinal Diseases
Medical Imaging

Background:

Macular telangiectasia type 2 (MacTel 2) is a bilateral retinal disease of unknown etiology.
Characterized by macular capillary network alterations and neurosensory atrophy, its prevalence is estimated at 0.1% in individuals over 40.
Clinical signs include crystalline deposits, ectatic capillaries, retinal pigment plaques, and foveal atrophy.

Purpose of the Study:

To review current knowledge on Macular telangiectasia type 2.
To discuss diagnostic findings from various imaging modalities and visual function tests.
To provide an overview of therapeutic approaches and future research directions.

Main Methods:

Review of existing literature on Macular telangiectasia type 2.
Analysis of findings from biomicroscopy, fluorescein angiography, and optical coherence tomography (OCT).
Evaluation of visual function tests and imaging techniques like adaptive optics and fundus autofluorescence.

Main Results:

MacTel 2 presents with characteristic telangiectatic capillaries and retinal pigment changes.
OCT reveals photoreceptor disruption and retinal atrophy.
Macular pigment depletion is a unique feature, unresponsive to lutein/zeaxanthin supplementation.
Anti-VEGF therapies show limited efficacy in non-neovascular stages.

Conclusions:

MacTel 2 diagnosis relies on characteristic clinical and imaging findings.
Current therapeutic strategies offer limited benefit, emphasizing the need for novel treatments.
Further research into structure-function correlations and animal models is crucial for developing effective therapies.